To Evaluate Transport Safety Between Different Scanning Methods for Patients in the Intensive Care Unit (ICU)
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Mar 31, 2025
Trial Information
Current as of November 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how safe it is for critically ill patients in the Intensive Care Unit (ICU) to have a PET scan, a type of imaging test that helps doctors see inside the body to figure out health problems. Unlike a regular CT scan, which uses X-rays, a PET scan involves a small amount of radioactivity to highlight areas that might be concerning. Since ICU patients are often very fragile, moving them for the scan can be risky. The study will compare the safety of the PET scan to that of a regular CT scan to find out if there are any additional risks for these patients.
To participate in this study, patients must be in the ICU and scheduled to receive a PET scan or a matched CT scan for comparison. The trial is open to all patients aged 65 and older. Throughout the study, participants will continue to receive their usual care, and researchers will closely monitor the scanning process to ensure safety. The findings may help determine if PET scans can be used more widely in the ICU setting, especially for diagnosing infections.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients receiving PET/CT during ICU admission (any indication)
- • Patients undergoing CT Thorax/Abdomen (matched cohort)
- Exclusion Criteria:
- • CT-scan for any acute indication (acute danger to vital parameters).
- • CT-Cerebrum
- • Registrion in the dutch Objection to medical research registry.
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported